Travere Therapeutics, Inc. · NASDAQ:TVTX
Rote William E. received 14,000 Travere Therapeutics, Inc. shares as an award (Form 4)
Traded Apr 13, 2026 · Filed Apr 15, 2026
On Apr 13, 2026, Rote William E. (Chief Research Officer) received 14,000 Travere Therapeutics, Inc. shares as an award under a trading plan, leaving 123,087 shares. Filed Apr 15, 2026 (Form 4).
- Awarded
- 14,000 shares
- Holding after
- 123,087 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Research Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 13, 2026 | Common Stock | Award | 14,000 | 123,087 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Rote William E.
- Travere Therapeutics, Inc. shareholders
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Rote William E. · May 6, 2026
- Form 4 · Rote William E. · Apr 23, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026